alexa Evaluation of Antianxiety Activity of Xanthine Oxidase

Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Evaluation of Antianxiety Activity of Xanthine Oxidase Inhibitors in Albino Mice

To read the full article Peer-reviewed Article PDF image


Background: Anxiety the most common mental health disorder affecting majority of the population. Serotonin is involved to be a major neurotransmitter in causing anxiety. Tryptophan is the only precursor of serotonin and xanthine oxidase is the endogenous activator of tryptophan pyrrolase enzyme which can result in reduced serotonin level. Xanthine oxidase inhibitors putatively inhibit the metabolism of tryptophan therefore leading to increase in serotonin level. Hence the study was planned to evaluate the antianxiety effect of xanthine oxidase inhibitors, allopurinol and febuxostat. Objective: To evaluate the antianxiety activity of Allopurinol 39mg/kg and Febuxostat 15.6mg/kg in comparison with control, Diazepam0.5mg/kg and with Fluoxetine10mg/kg. Methods: Elevated plus maze-Pre-treated animals were placed individually for 5mins in the maze. The number of entries into the open and closed arm, time spent in each arm and the no. of entries in both the arms was noted. Social interaction test-Pre-treated mice were isolated for 1hour before the test. In the test arena, the mice were observed for cumulative time spent in social interaction for a period of 10mins. All the results are expressed as Mean±SEM. Data are analyzed by ANOVA using Graph Pad Instat (GPIS) package, version 3.05. P < 0.05 was considered as significant. Results: Elevated plus maze- Administration of Allopurinol and Febuxostat significantly increased the time spent in open arms, p<0.001&p<0.018 respectively in comparison with control. Social interaction test- Administration of Allopurinol and Febuxostat significantly increased the time spent in social interaction, p<0.001 as compared to control. Conclusion: Both Allopurinol and Febuxostat possessed significant antiaxiety effects.


Recommended Journals

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version